🔎 Trials Near Me

Hjem › Depression › Washington

Depression kliniske forsøg i Washington

21 studier for Depression søger deltagere på steder i Washington.

Byer i Washington

Officiel studietekst (engelsk)

A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

  • Northwest Clinical Research Center, Bellevue
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 1. okt. 2026 · NCT07775300

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

  • Core Clinical Research, Everett
  • Seattle Neuropsychiatric Treatment Center, Seattle
RekruttererFase 3
Alder 18 til 85 · Alle køn · Opdateret 25. sep. 2026 · NCT06793397

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • Seattle Neuropsychiatric Treatment Center, Seattle
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 15. sep. 2026 · NCT07002034

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

  • Seaport Investigator Site, Everett
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 14. sep. 2026 · NCT07065240

PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study

  • Seattle NTC, Seattle
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT06713616

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

  • Draig Clinical Site, Bellevue
  • Draig Clinical Site, Seattle
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 2. sep. 2026 · NCT07610473

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

  • Draig Clinical Site, Bellevue
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 26. aug. 2026 · NCT07300969

Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression

  • VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 14. aug. 2026 · NCT07226232

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

  • Northwest Clinical Research Center, Bellevue
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 6. aug. 2026 · NCT07412756

E-Mindfulness Approaches for Living After Breast Cancer

  • Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale
RekruttererFase 3
Alder 18 til 50 · Alle køn · Opdateret 4. aug. 2026 · NCT06748222

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

  • Core Clinical Research, Everett
RekruttererFase 3
Alder 18 til 74 · Alle køn · Opdateret 3. aug. 2026 · NCT06775379

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Everett
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. jul. 2026 · NCT06966401

CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms

  • Madigan Army Medical Center, Fort Lewis
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 13. jul. 2026 · NCT05663034

TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

  • Seattle Children's Hospital, Seattle
RekruttererObservationsstudie
18 Months – 11 Years · Alle køn · Opdateret 6. jul. 2026 · NCT07048574

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

  • Center For Anxiety and Depression, Mercer Island
  • Seattle Neuropsychiatric Treatment Center, Seattle
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 15. jun. 2026 · NCT03887715

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

  • Seattle Neuropsychiatric Treatment Center, Bellevue
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 11. maj 2026 · NCT06524830

Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus

  • Seattle Children's Hospital, Seattle
Rekrutterer
Alder 12 til 22 · Alle køn · Opdateret 30. okt. 2025 · NCT06232304

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Everett
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 29. okt. 2025 · NCT06786624

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

  • Clinical Research Site, Everett
RekruttererFase 4
Alder 18 til 65 · Alle køn · Opdateret 23. jan. 2025 · NCT06223880

Lay-Delivered Behavioral Activation in Senior Centers

  • Enumclaw Senior Center, Enumclaw
  • Casa Latina, Seattle
  • Centro de la Raza, Seattle
  • og 1 flere
Rekrutterer
Alder 60 og opefter · Alle køn · Opdateret 15. okt. 2024 · NCT04621877

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.